FDA
-
-
-
-
-
-
-
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
-
-
-
-
-
-
-
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026
-
-
-
-
-
-
-
Daxor transitions to Exchange Act reporting framework
-
-
-
-
-
-
-
Daxor Corporation Unveils Next-Gen BVA Analyzer
-
-
-
-
-
-
-
Daxor receives FDA clearance for rapid blood volume analyzer
-
-
-
-
-
-
-
Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance
-
-
-
-
-
-
-
Daxor Corp. (DXR) Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
-
330,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

